Parkwalk and Oxford Sciences Innovation Fund invests £2M in Oxford Endovascular Limited

The University of Oxford Isis Fund II has completed an investment in Oxford Endovascular Limited, a company developing sophisticated mesh tubes to treat patients suffering from brain aneurysms. Parkwalk invested in a £2m round alongside the new Oxford Sciences Innovation Fund.

The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.  This diverts the blood away from the aneurysm, allowing it to heal.

 

Source: Parkwalk Advisors Press Release

Email this to someoneShare on LinkedInShare on FacebookTweet about this on TwitterShare on Google+